The aim of the project between Roboscreen GmbH and Paul-Flechsig-Institute Leipzig is to establish multi-parameter detection for neurodegenerative diseases in which several analytes are determined at the same time and a patient can then be classified according to the type of neurodegenerative disease. This is intended to provide a possibility of determining a specific therapeutic approach and the prospect of a possible earlier diagnosis of such pathological changes.
Supported by funding from the European Union and the Free State of Saxony from ERDF funds.
Analysis of CSF of AD (36), FTD (30), LBD (30), PDD (13) and patients w/o dementia (PSY, 30) using hSYN total ELISA, non-pTAU ELISA and new TDP43 ELISA.
Started in November 2019.